4BHF
Three dimensional structure of human gamma-butyrobetaine hydroxylase in complex with 4-(Trimethylammonio)pentanoate
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | MAX II BEAMLINE I911-3 |
Synchrotron site | MAX II |
Beamline | I911-3 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2012-11-11 |
Detector | MARRESEARCH |
Spacegroup name | H 3 2 |
Unit cell lengths | 107.450, 107.450, 205.280 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 26.720 - 2.050 |
R-factor | 0.15649 |
Rwork | 0.154 |
R-free | 0.20883 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 3o2g |
RMSD bond length | 0.012 |
RMSD bond angle | 1.486 |
Data reduction software | MOSFLM |
Data scaling software | SCALA |
Refinement software | REFMAC (5.7.0029) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 26.860 | 2.160 |
High resolution limit [Å] | 2.050 | 2.050 |
Rmerge | 0.090 | 0.410 |
Number of reflections | 27884 | |
<I/σ(I)> | 7.3 | 2.3 |
Completeness [%] | 97.3 | 98.8 |
Redundancy | 2.5 | 2.4 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 7 | 294 | 20 % PEG 3350, 1.5 % 1.6-DIAMINOHEXANE, 200 MM AMMONIUM CITRATE PH 7.0, 10 MM ZNSO4, 8 MM N-OXALYLGLYCINE, 4 MM INHIBITOR, PROTEIN 6.5 MG/ML, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 294K, TIME 2-7 DAYS |